ah 6809 has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, M; Iwamoto, J; Matsuoka, T; Miura, S; Mizokami, Y; Narasaka, T; Omata, T; Ootubo, T; Shimokobe, K; Takahashi, K; Takehara, H; Takeyama, H | 1 |
| Grant, V; Jabbour, HN; Sales, KJ | 1 |
2 other study(ies) available for ah 6809 and Adenocarcinoma
| Article | Year |
|---|---|
Involvement of cyclooxygenase-2--prostaglandin E2 pathway in interleukin-8 production in gastric cancer cells.
Topics: Adenocarcinoma; Arachidonic Acid; Biphenyl Compounds; Cell Line, Tumor; Cyclic AMP; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Fibroblasts; Gene Expression Regulation, Neoplastic; Helicobacter pylori; Humans; Interleukin-8; Nitrobenzenes; Prostaglandin Antagonists; Receptors, Prostaglandin E; RNA, Messenger; Stomach Neoplasms; Sulfonamides; Xanthones | 2006 |
Prostaglandin E2 and F2alpha activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element.
Topics: Adenocarcinoma; Cell Line, Tumor; Cyclooxygenase 2; Dinoprost; Dinoprostone; Endometrial Neoplasms; Enzyme Activation; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Regulation, Enzymologic; Genes, Reporter; Humans; Inositol 1,4,5-Trisphosphate; Promoter Regions, Genetic; Prostaglandin Antagonists; Receptors, Prostaglandin; Receptors, Prostaglandin E; Response Elements; Signal Transduction; Xanthones | 2008 |